IRIS Accounts Production v25.1.0.734 09124920 director 1.8.23 31.7.24 31.7.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh091249202023-07-31091249202024-07-31091249202023-08-012024-07-31091249202022-07-31091249202022-08-012023-07-31091249202023-07-3109124920ns15:EnglandWales2023-08-012024-07-3109124920ns14:PoundSterling2023-08-012024-07-3109124920ns10:Director12023-08-012024-07-3109124920ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3109124920ns10:SmallEntities2023-08-012024-07-3109124920ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3109124920ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3109124920ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3109124920ns10:FullAccounts2023-08-012024-07-3109124920ns10:CompanySecretary12023-08-012024-07-3109124920ns10:RegisteredOffice2023-08-012024-07-3109124920ns5:CurrentFinancialInstruments2024-07-3109124920ns5:CurrentFinancialInstruments2023-07-3109124920ns5:ShareCapital2024-07-3109124920ns5:ShareCapital2023-07-3109124920ns5:RetainedEarningsAccumulatedLosses2024-07-3109124920ns5:RetainedEarningsAccumulatedLosses2023-07-3109124920ns5:PlantMachinery2023-08-012024-07-3109124920ns5:PlantMachinery2023-07-3109124920ns5:PlantMachinery2024-07-3109124920ns5:PlantMachinery2023-07-3109124920ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3109124920ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31
REGISTERED NUMBER: 09124920 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2024

FOR

ACCLAIM BIOMEDICAL CONSULTING LTD

ACCLAIM BIOMEDICAL CONSULTING LTD (REGISTERED NUMBER: 09124920)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


ACCLAIM BIOMEDICAL CONSULTING LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTOR: R M J Young





SECRETARY: Mrs M T Young





REGISTERED OFFICE: 20 Sandford Leaze
Avening
Tetbury
Gloucestershire
GL8 8PB





REGISTERED NUMBER: 09124920 (England and Wales)





ACCOUNTANTS: Shiner Mitchell Fisher & Co Ltd
Smith House
George Street
Nailsworth
Stroud
Gloucestershire
GL6 0AG

ACCLAIM BIOMEDICAL CONSULTING LTD (REGISTERED NUMBER: 09124920)

BALANCE SHEET
31 JULY 2024

31.7.24 31.7.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 1,906 525

CURRENT ASSETS
Debtors 5 33,980 24,667
Cash at bank 72,647 146,430
106,627 171,097
CREDITORS
Amounts falling due within one year 6 61,764 76,703
NET CURRENT ASSETS 44,863 94,394
TOTAL ASSETS LESS CURRENT
LIABILITIES

46,769

94,919

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 46,669 94,819
SHAREHOLDERS' FUNDS 46,769 94,919

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 23 April 2025 and were signed by:





R M J Young - Director


ACCLAIM BIOMEDICAL CONSULTING LTD (REGISTERED NUMBER: 09124920)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1. STATUTORY INFORMATION

Acclaim Biomedical Consulting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 20% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

ACCLAIM BIOMEDICAL CONSULTING LTD (REGISTERED NUMBER: 09124920)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 August 2023 6,814
Additions 2,859
At 31 July 2024 9,673
DEPRECIATION
At 1 August 2023 6,289
Charge for year 1,478
At 31 July 2024 7,767
NET BOOK VALUE
At 31 July 2024 1,906
At 31 July 2023 525

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade debtors 33,980 24,667

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.24 31.7.23
£    £   
Trade creditors 31,775 12,330
Taxation and social security 22,197 53,523
Other creditors 7,792 10,850
61,764 76,703

7. RELATED PARTY DISCLOSURES

During the year, total dividends of £37,970 (2023 - £42,500) were paid to the director .

During the year the director and secretary made an unsecured interest free loan to the company. The balance owing to the director and secretary at 31st July 2024 was £4,430 (2023 - £9,690).

8. ULTIMATE CONTROLLING PARTY

The company was controlled through out the year by its director and secretary who between them own 100% of the issued share capital.